REVIEW
Add like
Add dislike
Add to saved papers

[Suicidal behaviour in borderline personality disorder].

Patients with borderline personality disorder have a substantially increased risk of self-destructive and suicidal behaviour, and are often seen as difficult to treat efficiently. A strong over-sensitivity to negative happenings in life, affective instability and impulsiveness are important risk factors for repetitive suicidal crises. Clinicians need to assess the suicide risk for individuals in general and more situation-specific risks. If there is a high risk, short term hospitalisation should be considered. Most patients will need long-term specialised treatment rather than a series of shorter treatments that might well worsen the prognosis. Several treatment models are currently available; among them are Dialectical Behaviour Therapy and Mentalisation-Based Therapy. The paper discusses how these treatment models address suicidal behaviour in patients with borderline personality disorder and the results that have been achieved in studies of treatment effectiveness.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app